DVL SRL
The score of DVL shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +11 % Total assets -11 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
DVL's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 14,211 € | ||||
| Equity | 190,568 € | ||||
| Cash | 7,858 € | ||||
| EBITDA | 23,341 € | ||||
| Total assets | 235,408 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Aug 2026
- Year ended 31 Dec 2024filed on 29 Aug 2025
- Year ended 31 Dec 2023filed on 29 Aug 2024
- Year ended 31 Dec 2022filed on 27 Jul 2023
- Year ended 31 Dec 2021filed on 20 Jul 2022
DVL's financial analysis
- Solvency81.0%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of DVL
DVL's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0445.254.744
- VAT number
- BE0445254744
- Peppol
- Registered · 0208:0445254744 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 25 Sep 1991
- Registered office
- 1703 Dilbeek
- Latest accounts
- 2025 · filed on 31 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
DVL (SRL) has been based in Dilbeek since 1991, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 14,211 € and equity of 190,568 €; its revenue is not published. Its solvency stands at 81.0%, above the median of its sector (44.2%).
Companies similar to DVL
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie Keereman Retail sale of pharmaceutical products Schaerbeek · balance sheet 235,291 €
- SyGoBioClin Retail sale of pharmaceutical products Kraainem · balance sheet 235,248 €
- Apoteek DE Decker Retail sale of pharmaceutical products Lebbeke · balance sheet 234,587 €
- Elapharma Retail sale of pharmaceutical products Brussels · balance sheet 236,353 €
- Lorophar Retail sale of pharmaceutical products Lincent · balance sheet 234,299 €
- Apotheek VAN Hoecke Retail sale of pharmaceutical products Kortrijk · balance sheet 234,019 €
- Pharmaphie EVG Retail sale of pharmaceutical products Evergem · balance sheet 229,312 €
- Sapos Retail sale of pharmaceutical products Aalst · balance sheet 241,792 €
Frequently asked questions about DVL
What is the revenue of DVL?
DVL files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of DVL?
In Belgium, the VAT number is the company number prefixed with BE: BE0445254744 for DVL, if the company is VAT-registered. Its company number (CBE) is 0445.254.744.
Where is the registered office of DVL?
According to the CBE register, the registered office of DVL is in 1703 Dilbeek.
What is the equity of DVL?
At the close of the 2025 financial year, the equity of DVL amounts to 190,568 €, a solvency of 81.0% of total assets.
Who manages DVL?
The register lists 1 active mandates at DVL. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of DVL
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →